Ms Yongping Qiao
(China)
Real-world early effectiveness and safety of inclisiran in China Pilot Zone: An interim analysis of 3-month data from a prospective non-interventional cohort study
Event: ESC Preventive Cardiology 2023
Topic: Lipid-Lowering Agents
Session: Late-Breaking Science session
